ArticlePharmaceutical research2012

Preclinical studies of YK-4-272, an inhibitor of class II histone deacetylases by disruption of nucleocytoplasmic shuttling.

Hye-Sik Kong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.